OS
DARE icon

Objectivity Squared’s Dare Bioscience DARE Stock Holding History

Objectivity Squared’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9K Hold
10,915
– – 0.01% 55
2025
Q4 		$21.1K Buy
+10,915
New +$21.8K 0.01% 57
2024
Q2 		– Sell
-2,250
Closed -$12.9K – 49
2024
Q1 		$12.9K Buy
2,250
+1,417
+170% +$6.94K 0.01% 47
2023
Q4 		$3.09K Buy
+833
New +$3.81K ﹤0.01% 44

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Objectivity Squared's DARE Position: Q1 2026 in Review

Objectivity Squared held its Dare Bioscience (DARE) position steady in Q1 2026 at 10,915 shares worth $19.9K. The position accounts for 0.01% of the portfolio, ranked #55.

Objectivity Squared first reported a position in DARE in Q4 2023 and has held it in 4 quarters since. The position peaked at $21.1K in Q4 2025. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Objectivity Squared held 10,915 shares of Dare Bioscience worth $19.9K as of Q1 2026.
  • Objectivity Squared left its Dare Bioscience share count unchanged in Q1 2026.
  • Dare Bioscience made up 0.01% of Objectivity Squared's portfolio in Q1 2026, its #55 holding.
  • Objectivity Squared first reported a position in Dare Bioscience in Q4 2023 and has held it in 4 quarters since.
  • Objectivity Squared's Dare Bioscience position peaked at $21.1K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Objectivity Squared's 13F filing for Q1 2026, filed 13 May 2026.